Skip to main content
CriticalFDAfda-F-0498-2020SALMONELLA CONTAMINATION

Emesa Foods Premium Sesame Tahini, in 28.2oz plastic jars, UPC 850005298267, 6 jars per case

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (Salmonella contamination). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
23
Recall Date
December 20, 2019
Issuing Agency
Hazard
Salmonella Contamination

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0498-2020.

product tested positive for salmonella

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0498-2020.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Emesa Foods Co or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0498-2020.

EMESA FOODS CO

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Emesa Foods Co Recall FAQ

Emesa Foods Co is the subject of a food safety report: Emesa Foods Premium Sesame Tahini, in 28.2oz plastic jars, UPC 850005298267, 6 jars per case. The notice was published on December 20, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 23 units are potentially affected.